Otsuka Holdings
4578.T
#705
Rank
S$44.99 B
Marketcap
S$85.20
Share price
-1.84%
Change (1 day)
31.40%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

EPS for Otsuka Holdings (4578.T)

EPS in 2025 (TTM): S$4.16

According to Otsuka Holdings 's latest financial reports the company's current EPS (TTM) is S$3.90. an increase over its 2024 EPS that were of S$5.11.

EPS history for Otsuka Holdings from 2009 to 2025

Annual EPS

Year EPS Change
2025S$5.558.5%
2024S$5.11153.9%
2023S$2.01-15.71%
2022S$2.39-6.18%
2021S$2.55-24.1%
2020S$3.3622.95%
2019S$2.7356.13%
2018S$1.75-25.11%
2017S$2.3325.99%
2016S$1.85-6.37%
2015S$1.98
2014N/A-100%
2013S$2.9818.06%
2012S$2.531.01%
2011S$2.5029.07%
2010S$1.94-94.47%
2009S$35.01